gilaxia / iStockphoto.com
BACIT, a former fund of funds, has combined with life sciences investment company Syncona to form a new investment vehicle using the latter’s name. LSIPR speaks to Arabella Cecil, one of the co-founders of BACIT, about the new company’s vision.
In 2012, there was a gap in the life sciences investment market.
Charities and researchers were faced with living hand to mouth—they received lump sums but were not sure whether they could spend the money and, if so, at what rate, because they didn’t know when the next payment was coming in.
That’s according to Arabella Cecil, a co-founder of what was, until December last year, investment fund BACIT, which is now known as Syncona after a combination of the businesses.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Arabella Cecil, Syncona, LSIPR 50 2017, researchers, BACIT, Syncona, life sciences, researchers,